Literature DB >> 31909991

Nanoscale Analysis of Randall's Plaques by Electron Energy Loss Spectromicroscopy: Insight in Early Biomineral Formation in Human Kidney.

Clément Gay1, Emmanuel Letavernier2,3,4, Marie-Christine Verpont2,3, Michael Walls1, Dominique Bazin5, Michel Daudon2,3,4, Nadine Nassif6, Odile Stéphan1, Marta de Frutos1.   

Abstract

Idiopathic kidney stones originate mainly from calcium phosphate deposits at the tip of renal papillae, known as Randall's plaques (RPs), also detected in most human kidneys without stones. However, little is known about the mechanisms involved in RP formation. The localization and characterization of such nanosized objects in the kidney remain a real challenge, making their study arduous. This study provides a nanoscale analysis of the chemical composition and morphology of incipient RPs, characterizing in particular the interface between the mineral and the surrounding organic compounds. Relying on data gathered from a calculi collection, the morphology and chemical composition of incipient calcifications in renal tissue were determined using spatially resolved electron energy-loss spectroscopy. We detected microcalcifications and individual nanocalcifications found at some distance from the larger ones. Strikingly, concerning the smaller ones, we show that two types of nanocalcifications coexist: calcified organic vesicles and nanometric mineral granules mainly composed of calcium phosphate with carbonate in their core. Interestingly, some of these nanocalcifications present similarities with those reported in physiological bone or pathological cardiovascular biominerals, suggesting possible common formation mechanisms. However, the high diversity of these nanocalcifications suggests that several mechanisms may be involved (nucleation on a carbonate core or on organic compounds). In addition, incipient RPs also appear to present specific features at larger scales, revealing secondary calcified structures embedded in a fibrillar organic material. Our study proves that analogies exist between physiological and pathological biominerals and provides information to understand the physicochemical processes involved in pathological calcification formation.

Entities:  

Keywords:  Randall’s plaques; biomineralization; calcium carbonate nanoparticles; calcium phosphate nanoparticles; electron energy-loss spectroscopy; kidney

Mesh:

Substances:

Year:  2020        PMID: 31909991     DOI: 10.1021/acsnano.9b07664

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  4 in total

Review 1.  Multiple Pathways for Pathological Calcification in the Human Body.

Authors:  Netta Vidavsky; Jennie A M R Kunitake; Lara A Estroff
Journal:  Adv Healthc Mater       Date:  2020-12-04       Impact factor: 9.933

2.  α-Klotho released from HK-2 cells inhibits osteogenic differentiation of renal interstitial fibroblasts by inactivating the Wnt-β-catenin pathway.

Authors:  Zewu Zhu; Shuhao Ruan; Yingcheng Jiang; Fang Huang; Weiping Xia; Jinbo Chen; Yu Cui; Cheng He; Feng Zeng; Yang Li; Zhiyong Chen; Hequn Chen
Journal:  Cell Mol Life Sci       Date:  2021-11-01       Impact factor: 9.261

3.  Osteogenic Differentiation of Renal Interstitial Fibroblasts Promoted by lncRNA MALAT1 May Partially Contribute to Randall's Plaque Formation.

Authors:  Zewu Zhu; Fang Huang; Weiping Xia; Huimin Zeng; Meng Gao; Yongchao Li; Feng Zeng; Cheng He; Jinbo Chen; Zhiyong Chen; Yang Li; Yu Cui; Hequn Chen
Journal:  Front Cell Dev Biol       Date:  2021-01-11

4.  First Direct Insight into the Local Environment and Dynamics of Water Molecules in the Whewellite Mineral Phase: Mechanochemical Isotopic Enrichment and High-Resolution 17O and 2H NMR Analyses.

Authors:  Ieva Goldberga; Nicolas Patris; Chia-Hsin Chen; Emilie Thomassot; Julien Trébosc; Ivan Hung; Zhehong Gan; Dorothée Berthomieu; Thomas-Xavier Métro; Christian Bonhomme; Christel Gervais; Danielle Laurencin
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2022-07-19       Impact factor: 4.177

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.